| Description |
1 online resource (179 p.) |
| Contents |
Cover -- Book Title -- Copyright Page -- Dedicated -- Contributors -- Foreword -- Preface -- Contents -- Article-1: Apremilast in Psoriasis-A Prospective Real-world Study -- Article-2: Comparative Effectiveness of Abatacept, Apremilast, Secukinumab and Ustekinumab Treatment of Psoriatic Arthritis: A Systematic Review and Network Meta-analysis -- Article-3: Management of Common Side Effects of Apremilast -- Article-4: Apremilast for the Treatment of Moderate-to-Severe Palmoplantar Psoriasis: Results from a Double-Blind, Placebo-Controlled, Randomized Study |
|
Article-5: Long-term Safety and Tolerability of Apremilast in Patients with Psoriasis: Pooled Safety Analysis for ≥156 Weeks from 2 Phase 3, Randomized Controlled Trials (ESTEEM 1 and 2) -- Article-6: Secukinumab and Apremilast Combination Therapy for Recalcitrant Psoriasis -- Article-7: Apremilast: A Review in Psoriasis and Psoriatic Arthritis -- Article-8: Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity |
|
Article-9: Long-term Real-life Safety Profile and Effectiveness of Fumaric Acid Esters in Psoriasis Patients: A Single-Centre, Retrospective, Observational Study -- Article-10: Association between Circulating 25-hydroxyvitamin D Levels and Psoriasis, and Correlation with Disease Severity: A Metaanalysis -- Article-11: Maintenance of Skin Clearance with Ixekizumab Treatment of Psoriasis: Three-Year Results from the UNCOVER-3 Study -- Article-12: Psoriasis and the Risk of Diabetes: A Prospective Populationbased Cohort Study |
|
Article-13: Psoriatic Patients with Chronic Viral Hepatitis do not have an Increased Risk of Liver Cirrhosis Despite Long-term Methotrexate Use: Real-world Data from a Nationwide Cohort Study in Taiwan -- Article-14: Reporting of Outcomes in Randomized Controlled Trials on Nail Psoriasis: A Systematic Review -- Article-15: Risk of Cancer in Patients with Psoriasis on Biological Therapies: A Systematic Review -- Article-16: Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis |
|
Article-17: Secukinumab Treatment of Moderate to Severe Plaque Psoriasis in Routine Clinical Care: Real-life Data of Prior and Concomitant Use of Psoriasis Treatments from the PROSPECT Study -- Article-18: Serum Levels of Psoriasin (S100A7) and Koebnerisin (S100A15) as Potential Markers of Atherosclerosis in Patients with Psoriasis -- Article-19: Simulating the Life Course of Psoriasis Patients: The Interplay between Therapy Intervention and Marital Status -- Article-20: Smoking Paradox in the Development of Psoriatic Arthritis among Patients with Psoriasis: A Population-based Study |
| Notes |
Description based upon print version of record |
|
Article-21: Stricturing and Fistulizing Crohn's Disease is Associated with Anti-tumor Necrosis Factor-induced Psoriasis in Patients with Inflammatory Bowel Disease |
| Subject |
Psoriasis.
|
|
Psoriasis
|
|
Psoriasis.
|
| Form |
Electronic book
|
| ISBN |
9789390020355 |
|
9390020352 |
|
9789390281237 |
|
9390281237 |
|
